Bank of Montreal’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $606K | Sell |
4,407
-11
| -0.2% | -$1.51K | ﹤0.01% | 1912 |
|
|
2025
Q1 | $797K | Buy |
4,418
+1,093
| +33% | +$197K | ﹤0.01% | 1703 |
|
|
2024
Q4 | $521K | Buy |
3,325
+179
| +6% | +$28K | ﹤0.01% | 1947 |
|
|
2024
Q3 | $557K | Buy |
3,146
+210
| +7% | +$37.2K | ﹤0.01% | 2068 |
|
|
2024
Q2 | $540K | Buy |
+2,936
| New | +$540K | ﹤0.01% | 2106 |
|
|
2023
Q1 | – | Sell |
-21,698
| Closed | -$1.76M | – | 3568 |
|
|
2022
Q4 | $1.76M | Buy |
21,698
+60
| +0.3% | +$4.86K | ﹤0.01% | 1559 |
|
|
2022
Q3 | $1.55K | Buy |
+21,638
| New | +$1.55K | ﹤0.01% | 1655 |
|
|
2021
Q2 | – | Sell |
-491
| Closed | -$37K | – | 4055 |
|
|
2021
Q1 | $37K | Sell |
491
-1,603
| -77% | -$121K | ﹤0.01% | 3439 |
|
|
2020
Q4 | $139K | Buy |
2,094
+1,468
| +235% | +$97.4K | ﹤0.01% | 2963 |
|
|
2020
Q3 | $29K | Sell |
626
-333
| -35% | -$15.4K | ﹤0.01% | 3256 |
|
|
2020
Q2 | $41K | Buy |
+959
| New | +$41K | ﹤0.01% | 3155 |
|
|
2020
Q1 | – | Sell |
-1,326
| Closed | -$73K | – | 3953 |
|
|
2019
Q4 | $73K | Buy |
1,326
+406
| +44% | +$22.4K | ﹤0.01% | 3135 |
|
|
2019
Q3 | $32K | Buy |
920
+189
| +26% | +$6.57K | ﹤0.01% | 3339 |
|
|
2019
Q2 | $29K | Buy |
+731
| New | +$29K | ﹤0.01% | 3490 |
|